SHC — SOTERA HEALTH CO
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying SHC?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their SHC position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).
- +1 tracked investor added or increased positions last quarter (David Einhorn)
- +5 tracked investors reported holding SHC at their latest filing
- +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About SOTERA HEALTH CO (SHC)
SOTERA HEALTH CO (SHC) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by David Einhorn (DME Capital Management, LP), valued at $73M. Across recent filings, tracked investors recorded 3 new positions, 3 increased, 3 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in SHC
How many top investors track SHC
A small number of top investors own this.
SHC Ownership Composition
How SOTERA HEALTH CO is held across tracked investor types, based on reported 13F positions.
- Value & Distressed45.6%
- Multi-Strategy / Quant43.4%
- Macro11.1%
Tracked investors currently reporting SHC
1 tracked investor has since exited this position — listed separately below.
- David EinhornJun 30, 2026DME Capital Management, LPShares4.1MValue$73.4M% Portfolio1.88%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares2MValue$35.6M% Portfolio0.00%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares1.9MValue$34.3M% Portfolio0.01%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares985.1KValue$17.5M% Portfolio0.02%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares19.2KValue$341.5K% Portfolio0.00%
Previously held SHC
These investors reported SHC in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Steve Cohen | Point72 Asset Management | 1.6M | $23.1M | Mar 31, 2026 |
Recent activity
- Unchanged$5.7M(0.00%)Feb 14, 2024
- Reduced$3.6M(-10.94%)May 15, 2024
- Unchanged$3.6M(0.00%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- $2.6MAug 14, 2025
- Reduced$2.8M(-22.73%)Nov 14, 2025
- Increased$8.1M(155.44%)Feb 17, 2026
- Increased$29.6M(347.82%)May 15, 2026
- Increased$73.4M(100.20%)Aug 14, 2026
- New$10MMay 15, 2026
- Reduced$341.5K(-97.23%)Aug 14, 2026
- $5MNov 14, 2023
Frequently asked questions
- How many institutional investors hold SHC?
- 5 tracked institutional investors disclosed a position in SHC (SOTERA HEALTH CO) in their most recent 13F filing.
- Who is the largest institutional holder of SHC?
- David Einhorn, DME Capital Management, LP, holds the largest disclosed position in SHC, valued at $73M.
- Did institutional ownership of SHC increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 3 increased, 3 reduced, and 1 fully exited SHC.
- Where does this SHC ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.